{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:25:59Z","timestamp":1794327959758,"version":"4.9.0"},"reference-count":55,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome with an inherited form (primary HLH [pHLH]), of which familial HLH (FHL) is most prevalent, and an acquired (non-Mendelian) form (secondary HLH); both potentially fatal. As more patients survive, evaluating long-term morbidity, especially neurological complications, is important. Here, we report on central nervous system involvement at onset, its impact on mortality and morbidity, and long-term follow-up in 365 children aged &amp;lt;18 years enrolled in the prospective multinational HLH-2004 study. This treatment included etoposide; dexamethasone; cyclosporine; and, for selected patients, intrathecal methotrexate\/prednisolone; followed by hematopoietic stem cell transplantation (HSCT) for pHLH. At diagnosis, 33% had neurological symptoms and 57% abnormal cerebral spinal fluid (CSF); 33% and 73%, respectively, in children with verified FHL. Elevated CSF protein was associated with inferior survival in univariate analyses, and multivariate analyses revealed reduced survival in children with both neurological symptoms and abnormal CSF. Overall, 32% of post-HSCT long-term survivors had neurological symptoms at last follow-up, more often in children with abnormal CSF at diagnosis; psychomotor retardation affected 25%, seizures 11%, and attention deficit hyperactivity disorder (ADHD)\/autism 10% (at least). Seizures and psychomotor retardation were detected before HSCT in approximately half of children who received HSCT; however, at least 3 years after HSCT in one-third. The median time for reporting ADHD\/autism was 5 years after HSCT. Late neurological complications were reported in 7% of long-term survivors without HSCT. In conclusion, late neurological complications remain a major concern in pHLH, CSF evaluation at diagnosis is valuable, and long follow-up is important because complications may be diagnosed late. This trial was registered at www.clinicaltrials.gov as #NCT00426101.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2026020485","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T20:57:51Z","timestamp":1787345871000},"page":"7429-7449","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Central nervous system involvement in children with hemophagocytic lymphohistiocytosis: an HLH-2004 study report"],"prefix":"10.1182","volume":"10","author":[{"given":"Elisabet","family":"Bergsten","sequence":"first","affiliation":[{"name":"1Childhood Cancer Research Unit, Department of Women\u2019s and Children\u2019s Health, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1908-6671","authenticated-orcid":false,"given":"Maurizio","family":"Aric\u00f3","sequence":"additional","affiliation":[{"name":"2Interdisciplinary Department of Medicine, Aldo Moro University of Bari, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5012-0137","authenticated-orcid":false,"given":"Itziar","family":"Astigarraga","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Hospital Universitario Cruces, Biobizkaia Health Research Institute, University of the Basque Country UPV\/EHU, Barakaldo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Ishii","sequence":"additional","affiliation":[{"name":"4Imabari City Medical Association General Hospital, Imabari, Ehime, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gritta","family":"Janka","sequence":"additional","affiliation":[{"name":"5Department of Pediatric Hematology and Oncology, University Medical Center Hamburg, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2484-1456","authenticated-orcid":false,"given":"Stephan","family":"Ladisch","sequence":"additional","affiliation":[{"name":"6Center for Cancer and Immunology Research, Children\u2019s National Research Institute, Children\u2019s National Medical Center, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Lehmberg","sequence":"additional","affiliation":[{"name":"7Division of Pediatric Stem Cell Transplantation and Immunology, Department of Pediatric Hematology and Oncology, University Medical Center Hamburg, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0725-6263","authenticated-orcid":false,"given":"Kenneth L.","family":"McClain","sequence":"additional","affiliation":[{"name":"8Texas Children\u2019s Cancer Center, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6471-8423","authenticated-orcid":false,"given":"Milen","family":"Minkov","sequence":"additional","affiliation":[{"name":"9Center for Child Health, Growth, and Development, Sigmund Freud University, Vienna, Austria"},{"name":"10Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasanta","family":"Nanduri","sequence":"additional","affiliation":[{"name":"11Department of Pediatrics, Watford General Hospital, Watford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego A.","family":"Rosso","sequence":"additional","affiliation":[{"name":"12Department of Pediatric Hematology and Oncology, Hospital de Ni\u00f1os Pedro de Elizalde, Buenos Aires, Argentina"},{"name":"13Department of Pediatrics, Hospital de Clinicas General San Martin, University of Buenos Aires, Buenos Aires, Argentina"},{"name":"14Instituto de Farmacolog\u00eda, Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6192-9812","authenticated-orcid":false,"given":"Elena","family":"Sieni","sequence":"additional","affiliation":[{"name":"15Pediatric Hematology\/Oncology Department, Meyer Children's Hospital IRCCS, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2878-4463","authenticated-orcid":false,"given":"AnnaCarin","family":"Horne","sequence":"additional","affiliation":[{"name":"16Division of Clinical Pediatrics, Department of Women\u2019s and Children\u2019s Health, Karolinska Institute, Stockholm, Sweden"},{"name":"17Astrid Lindgren Children\u2019s Hospital, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0629-2126","authenticated-orcid":false,"given":"Jan-Inge","family":"Henter","sequence":"additional","affiliation":[{"name":"1Childhood Cancer Research Unit, Department of Women\u2019s and Children\u2019s Health, Karolinska Institute, Stockholm, Sweden"},{"name":"17Astrid Lindgren Children\u2019s Hospital, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,11,2]]},"reference":[{"issue":"3","key":"2026111011014040100_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00443367","article-title":"Familial hemophagocytic lymphohistiocytosis","volume":"140","author":"Janka","year":"1983","journal-title":"Eur J Pediatr"},{"issue":"6","key":"2026111011014040100_bib2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMra2314005","article-title":"Hemophagocytic lymphohistiocytosis","volume":"392","author":"Henter","year":"2025","journal-title":"N Engl J Med"},{"issue":"5","key":"2026111011014040100_bib3","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.jaip.2018.05.031","article-title":"Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH Steering Committee of the Histiocyte Society","volume":"6","author":"Ehl","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"22","key":"2026111011014040100_bib4","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","volume":"127","author":"Emile","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2026111011014040100_bib5","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood-2007-02-074468","article-title":"Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients","volume":"110","author":"Bryceson","year":"2007","journal-title":"Blood"},{"issue":"12","key":"2026111011014040100_bib6","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1172\/JCI40732","article-title":"Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells","volume":"119","author":"C\u00f4te","year":"2009","journal-title":"J Clin Invest"},{"issue":"4","key":"2026111011014040100_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","article-title":"Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)","volume":"115","author":"Feldmann","year":"2003","journal-title":"Cell"},{"issue":"10","key":"2026111011014040100_bib8","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1111\/apa.15889","article-title":"Clinical features, diagnosis and therapy of familial haemophagocytic lymphohistiocytosis","volume":"110","author":"Janka","year":"2021","journal-title":"Acta Paediatr"},{"key":"2026111011014040100_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.coi.2017.08.004","article-title":"Hemophagocytic syndrome: primary forms and predisposing conditions","volume":"49","author":"Sepulveda","year":"2017","journal-title":"Curr Opin Immunol"},{"issue":"5446","key":"2026111011014040100_bib10","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"issue":"4","key":"2026111011014040100_bib11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","article-title":"Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11","volume":"85","author":"zur Stadt","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2026111011014040100_bib12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/hmg\/ddi076","article-title":"Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11","volume":"14","author":"zur Stadt","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"23","key":"2026111011014040100_bib13","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Ros\u00e9e","year":"2019","journal-title":"Blood"},{"issue":"9927","key":"2026111011014040100_bib14","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"issue":"5","key":"2026111011014040100_bib15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","article-title":"HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH Study Group of the Histiocyte Society","volume":"28","author":"Henter","year":"1997","journal-title":"Med Pediatr Oncol"},{"issue":"2","key":"2026111011014040100_bib16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"22","key":"2026111011014040100_bib17","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood.2024025077","article-title":"Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited","volume":"144","author":"Henter","year":"2024","journal-title":"Blood"},{"issue":"2","key":"2026111011014040100_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00431-006-0258-1","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","volume":"166","author":"Janka","year":"2007","journal-title":"Eur J Pediatr"},{"issue":"2","key":"2026111011014040100_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0046-8177(84)80057-X","article-title":"Neuropathology of familial erythrophagocytic lymphohistiocytosis: six cases and review of the literature","volume":"15","author":"Akima","year":"1984","journal-title":"Hum Pathol"},{"key":"2026111011014040100_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejpn.2021.08.002","article-title":"Neurological involvement in secondary hemophagocytic lymphohistiocytosis in children","volume":"34","author":"Benallegue","year":"2021","journal-title":"Eur J Paediatr Neurol"},{"issue":"25","key":"2026111011014040100_bib21","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","volume":"130","author":"Bergsten","year":"2017","journal-title":"Blood"},{"issue":"15","key":"2026111011014040100_bib22","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1182\/bloodadvances.2020002101","article-title":"Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study","volume":"4","author":"Bergsten","year":"2020","journal-title":"Blood Adv"},{"issue":"6","key":"2026111011014040100_bib23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s10875-020-00814-6","article-title":"Neuroinflammatory disease as an isolated manifestation of hemophagocytic lymphohistiocytosis","volume":"40","author":"Blincoe","year":"2020","journal-title":"J Clin Immunol"},{"issue":"10","key":"2026111011014040100_bib24","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1007\/s00330-023-09649-2","article-title":"Spectrum of neuroradiological manifestations in primary hemophagocytic lymphohistiocytosis: a comparative study of EBV-induced versus non-EBV-induced forms in 75 genetically confirmed pediatric cases","volume":"33","author":"Charpentier","year":"2023","journal-title":"Eur Radiol"},{"issue":"15","key":"2026111011014040100_bib25","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1212\/WNL.0b013e31824f800a","article-title":"CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis","volume":"78","author":"Deiva","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"2026111011014040100_bib26","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1182\/blood.V89.3.794","article-title":"Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis","volume":"89","author":"Haddad","year":"1997","journal-title":"Blood"},{"issue":"8785","key":"2026111011014040100_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0140-6736(92)91008-V","article-title":"Cerebromeningeal haemophagocytic lymphohistiocytosis","volume":"339","author":"Henter","year":"1992","journal-title":"Lancet"},{"issue":"3","key":"2026111011014040100_bib28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0022-3476(97)70196-3","article-title":"Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis","volume":"130","author":"Henter","year":"1997","journal-title":"J Pediatr"},{"issue":"3","key":"2026111011014040100_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2141.2007.06922.x","article-title":"Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis","volume":"140","author":"Horne","year":"2008","journal-title":"Br J Haematol"},{"issue":"1","key":"2026111011014040100_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11940-017-0439-4","article-title":"How to treat involvement of the central nervous system in hemophagocytic lymphohistiocytosis?","volume":"19","author":"Horne","year":"2017","journal-title":"Curr Treat Options Neurol"},{"issue":"3","key":"2026111011014040100_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pediatrneurol.2013.10.014","article-title":"Central nervous system involvement in hemophagocytic lymphohistiocytosis: a single-center experience","volume":"50","author":"Jovanovic","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"12","key":"2026111011014040100_bib32","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/jnen\/nly094","article-title":"Histopathologic correlates of familial hemophagocytic lymphohistiocytosis isolated to the central nervous system","volume":"77","author":"Solomon","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"issue":"17","key":"2026111011014040100_bib33","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","article-title":"Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol","volume":"118","author":"Trottestam","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2026111011014040100_bib34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/pbc.22239","article-title":"Frequency and development of CNS involvement in Chinese children with hemophagocytic lymphohistiocytosis","volume":"54","author":"Yang","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"15","key":"2026111011014040100_bib35","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.4103\/0366-6999.237409","article-title":"Central nervous system involvement in 179 Chinese children with hemophagocytic lymphohistiocytosis","volume":"131","author":"Zhao","year":"2018","journal-title":"Chin Med J"},{"issue":"4","key":"2026111011014040100_bib36","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1046\/j.1365-2141.1999.01625.x","article-title":"Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients","volume":"106","author":"D\u00fcrken","year":"1999","journal-title":"Br J Haematol"},{"issue":"2","key":"2026111011014040100_bib37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0022-3476(86)81002-2","article-title":"Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis","volume":"108","author":"Fischer","year":"1986","journal-title":"J Pediatr"},{"issue":"2","key":"2026111011014040100_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/ped.12314","article-title":"Current research on chronic active Epstein-Barr virus infection in Japan","volume":"56","author":"Fujiwara","year":"2014","journal-title":"Pediatr Int"},{"issue":"12","key":"2026111011014040100_bib39","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood.V90.12.4743","article-title":"Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors","volume":"90","author":"Jabado","year":"1997","journal-title":"Blood"},{"issue":"1","key":"2026111011014040100_bib40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/bmt.2010.122","article-title":"Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection","volume":"46","author":"Kawa","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"2026111011014040100_bib41","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood.2023022281","article-title":"Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation","volume":"143","author":"B\u00f6hm","year":"2024","journal-title":"Blood"},{"issue":"8","key":"2026111011014040100_bib42","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood.V82.8.2319.2319","article-title":"Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A","volume":"82","author":"St\u00e9phan","year":"1993","journal-title":"Blood"},{"issue":"6","key":"2026111011014040100_bib43","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood-2004-02-0733","article-title":"A91V is a polymorphism in the perforin gene not causative of an FHLH phenotype","volume":"104","author":"Zur Stadt","year":"2004","journal-title":"Blood"},{"issue":"2","key":"2026111011014040100_bib44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1542\/peds.2009-1181","article-title":"Defining cerebrospinal fluid white blood cell count reference values in neonates and young infants","volume":"125","author":"Kestenbaum","year":"2010","journal-title":"Pediatrics"},{"issue":"1","key":"2026111011014040100_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jhm.711","article-title":"Age-specific reference values for cerebrospinal fluid protein concentration in neonates and young infants","volume":"6","author":"Shah","year":"2011","journal-title":"J Hosp Med"},{"issue":"4","key":"2026111011014040100_bib46","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.1542\/peds.2005-1789","article-title":"Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients","volume":"117","author":"Ouach\u00e9e-Chardin","year":"2006","journal-title":"Pediatrics"},{"issue":"2","key":"2026111011014040100_bib47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaci.2025.09.014","article-title":"Late effects after hematopoietic stem cell transplantation in patients with HLH: a Histiocyte Society, PDWP, IEWP, and TCWP EBMT Study","volume":"157","author":"Ramme","year":"2026","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"2026111011014040100_bib48","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/pbc.24475","article-title":"Persistent defective membrane trafficking in epithelial cells of patients with familial hemophagocytic lymphohistiocytosis type 5 due to STXBP2\/MUNC18-2 mutations","volume":"60","author":"Stepensky","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"10146","key":"2026111011014040100_bib49","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0140-6736(18)31129-2","article-title":"Autism spectrum disorder","volume":"392","author":"Lord","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"2026111011014040100_bib50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S2215-0366(17)30167-0","article-title":"ADHD in children and young people: prevalence, care pathways, and service provision","volume":"5","author":"Sayal","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"2026111011014040100_bib51","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter","year":"2002","journal-title":"Blood"},{"issue":"5","key":"2026111011014040100_bib52","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2141.2005.05501.x","article-title":"Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis","volume":"129","author":"Horne","year":"2005","journal-title":"Br J Haematol"},{"issue":"6","key":"2026111011014040100_bib53","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.bbmt.2018.01.022","article-title":"Outcomes of children with hemophagocytic lymphohistiocytosis given allogeneic hematopoietic stem cell transplantation in Italy","volume":"24","author":"Messina","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2026111011014040100_bib54","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/bmt.2009.34","article-title":"Patients with early relapse of primary hemophagocytic syndromes or with persistent CNS involvement may benefit from immediate hematopoietic stem cell transplantation","volume":"44","author":"Sparber-Sauer","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2026111011014040100_bib55","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/bjh.70251","article-title":"Assessment of intrathecal therapy in the treatment of familial haemophagocytic lymphohistiocytosis","volume":"208","author":"Zivkovic","year":"2026","journal-title":"Br J Haematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/21\/7429\/2598708\/blooda_adv-2026-020485-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/21\/7429\/2598708\/blooda_adv-2026-020485-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:01:52Z","timestamp":1794326512000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/21\/7429\/570455\/Central-nervous-system-involvement-in-children"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,2]]},"references-count":55,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026,11,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026020485","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11,10]]},"published":{"date-parts":[[2026,11,2]]}}}